Cover Image

Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma

The development of resistance to trastuzumab in HER2-positive gastroesophageal cancer remains a problem. The use of dual HER2 blockade to overcome this is a therapeutic strategy that should be researched more extensively.

Saved in:
Bibliographic Details
Main Authors: Von Cheong, E., Ho, Gwo Fuang
Format: Article
Published: Wiley 2021
Subjects:
R Medicine (General)
RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Online Access:http://eprints.um.edu.my/34953/
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.um.eprints.34953
record_format eprints
spelling my.um.eprints.349532022-05-23T08:02:52Z http://eprints.um.edu.my/34953/ Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma Von Cheong, E. Ho, Gwo Fuang R Medicine (General) RC0254 Neoplasms. Tumors. Oncology (including Cancer) The development of resistance to trastuzumab in HER2-positive gastroesophageal cancer remains a problem. The use of dual HER2 blockade to overcome this is a therapeutic strategy that should be researched more extensively. Wiley 2021-04 Article PeerReviewed Von Cheong, E. and Ho, Gwo Fuang (2021) Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma. Clinical Case Reports, 9 (4). pp. 2264-2268. ISSN 2050-0904, DOI https://doi.org/10.1002/ccr3.4009 <https://doi.org/10.1002/ccr3.4009>. 10.1002/ccr3.4009
institution Universiti Malaya
building UM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaya
content_source UM Research Repository
url_provider http://eprints.um.edu.my/
topic R Medicine (General)
RC0254 Neoplasms. Tumors. Oncology (including Cancer)
spellingShingle R Medicine (General)
RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Von Cheong, E.
Ho, Gwo Fuang
Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
description The development of resistance to trastuzumab in HER2-positive gastroesophageal cancer remains a problem. The use of dual HER2 blockade to overcome this is a therapeutic strategy that should be researched more extensively.
format Article
author Von Cheong, E.
Ho, Gwo Fuang
author_facet Von Cheong, E.
Ho, Gwo Fuang
author_sort Von Cheong, E.
title Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
title_short Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
title_full Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
title_fullStr Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
title_full_unstemmed Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
title_sort dual her2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
publisher Wiley
publishDate 2021
url http://eprints.um.edu.my/34953/
_version_ 1735409639104708608
score 13.160551

Similar Items